Project: INDUSTRIAL PERSONALIZED TISSUE-ENGINEERING FOR THE REGENERATION OF ARTERIES
| Acronym | iPETRA (Reference Number: 115315) |
| Duration | 01/06/2021 - 01/06/2024 |
| Project Topic | The objective of the iPETRA project is to prepare a novel regenerative medicine product, personalized tissue-engineered artery (P-TEA) grafts, for a first-in-man clinical trial to replace defective tissues and restore physiological function for the large patient groups affected by peripheral artery disease (PAD). The project will generate the required process scale-up and pre-clinical safety data necessary for European regulatory approval and market introduction. |
| Network | Eurostars 2 |
| Call | Eurostars Cut–off 15 |
Project partner
| Number | Name | Role | Country |
|---|---|---|---|
| 1 | Froceth | Partner | Lithuania |
| 2 | RISE Research Institutes of Sweden | Partner | Sweden |
| 3 | Sahlgrenska University Hospital | Partner | Sweden |
| 4 | VERIGRAFT AB | Coordinator | Sweden |